From inflammation to carcinogenesis: MiRNA regulates epithelial-mesenchymal transition to facilitate malignant progression of gastric precancerous lesions
Open Access
- 28 September 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1959240
Abstract
The process of chronic gastritis transforming into gastric cancer (GC) follows the classic Correa cascade, with persistent inflammation driving the stepwise transition from normal gastric mucosa through superficial gastritis, atrophic gastritis, intestinal metaplasia, dysplasia, and ultimately carcinoma. Among these stages, intestinal metaplasia and dysplasia occurring on an atrophic mucosal background are widely regarded as the most common gastric precancerous lesions (GPL) because of their pronounced carcinogenic risk. Chronic inflammation can induce epithelial–mesenchymal transition (EMT), thereby accelerating gastric malignant progression. In the GPL stage, the inflammatory gastric microenvironment commonly induces partial EMT (pEMT); importantly, this state is partly reversible and may be amenable to intervention to slow disease progression. As lesions advance, epithelial cells more fully undergo EMT, acquiring greater motility, invasiveness, and metastatic capability, which increases susceptibility to malignant conversion. MicroRNAs (miRNAs) are key molecular regulators in the transition from chronic gastritis to GC through EMT modulation. This review comprehensively discusses inflammation-driven EMT activation and functionally classifies pro-EMT oncomiRNAs (e.g., miR-21, miR-155) and anti-EMT tumor-suppressive miRNAs (e.g., miR-200 family, let-7 family, miR-34a), delineating a complex crosstalk network among inflammation, miRNA, and EMT. We further evaluate miRNAs as non-invasive biomarkers for early detection and prognosis of GPL and discuss emerging therapeutic strategies targeting the miRNA–EMT axis, including nanoparticle- or exosome-based delivery systems, miRNA antagonists, and miRNA sponges. Nevertheless, clinical application of circulating miRNAs remains limited by insufficient assay standardization and validation, incomplete target specificity, off-target effects, suboptimal delivery efficiency, and a lack of large-scale clinical evidence. By integrating molecular mechanisms and transformation status of miRNA-EMT axis in GPL, this review provides new insights for precision prevention and targeted intervention in gastric carcinogenesis.Keywords
Funding Information
- Beijing Municipal Health Commission
- National Natural Science Foundation of China
This publication has 189 references indexed in Scilit:
- Therapeutic Potential of miR‐384 in Gastric Cancer: Dual Regulation of Epithelial‐Mesenchymal Transition and Cell Proliferation Through Direct Targeting of CTNNB1Journal of Biochemical and Molecular Toxicology, 2025
- HOXA10‐AS Enhances Gastric Cancer Cell Proliferation, Migration, and Invasion via the p38 MAPK/STAT3 Signaling PathwayJournal of Biochemical and Molecular Toxicology, 2025
- Helicobacter pylori promotes gastric cancer progression by activating the TGF-β/Smad2/EMT pathway through HKDC1Cellular and Molecular Life Sciences, 2024
- Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistanceNaunyn-Schmiedeberg's Archives of Pharmacology, 2024
- MiR‐192‐5p/RB1/NF‐κBp65 signaling axis promotes IL‐10 secretion during gastric cancer EMT to induce Treg cell differentiation in the tumour microenvironmentClinical and Translational Medicine, 2022
- Identification of serum microRNAs as potential diagnostic biomarkers for detecting precancerous lesions of gastric cancerAnnals of Gastroenterological Surgery, 2022
- Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric CancerJAMA Network Open, 2021
- A novel combination of serum microRNAs for the detection of early gastric cancerGastric Cancer, 2021
- Chronic CagA‐positive Helicobacter pylori infection with MNNG stimulation synergistically induces mesenchymal and cancer stem cell‐like properties in gastric mucosal epithelial cellsJournal of Cellular Biochemistry, 2019
- Epithelial-mesenchymal transition in human gastric cancer cell lines induced by TNF-α-inducing protein ofHelicobacter pyloriInternational Journal of Cancer, 2013